Drug treatment for spinal muscular atrophy type I
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To review systematically the evidence from randomised controlled trials concerning the efficacy and safety of any drug therapy designed to slow or arrest the progress of the disease in SMA type I. We will perform a separate Cochrane review on SMA type II and III.